Breaking News, Collaborations & Alliances, Trials & Filings

FDA Approves Bionpharma Generic Tablet for HIV/AIDS Treatment

The etravirine tablet was developed using STEERLife’s proprietary continuous manufacturing platform.

Author Image

By: Patrick Lavery

Content Marketing Editor

Bionpharma and STEERLife, the life sciences division of STEER World, have announced U.S. FDA approval of a generic tablet for treatment of HIV/AIDS. Etravirine, developed using STEERLife’s proprietary continuous manufacturing platform known as FragMelt, received Abbreviated New Drug Application status. Bionpharma will now lead commercialization and distribution of etravirine in the United States. Bionpharma, STEERLife Leaders React “This ANDA approval is a testament to the power of alig...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters